ApoE-/- PGC-1α-/- mice display reduced IL-18 levels and do not develop enhanced atherosclerosis

PLoS ONE

Volumn 5, Issue 10, 2010, Pages

  Stein, Sokrates ^a   Lohmann, Christine ^a   Handschin, Christoph ^b   Stenfeldt, Elin ^c   Borén, Jan ^c   Lü scher, Thomas F ^a   Matter, Christian M ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 18; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; CHOLESTEROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PPARGC1A PROTEIN, MOUSE; TRANSACTIVATOR PROTEIN;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BODY FAT; CELL DIFFERENTIATION; CHOLESTEROL DIET; CONTROLLED STUDY; DISEASE ASSOCIATION; EPIDIDYMIS FAT; GENE EXPRESSION; GLUCOSE METABOLISM; INFLAMMATION; INTRAABDOMINAL FAT; LIPID METABOLISM; LIVER WEIGHT; MACROPHAGE; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; WEIGHT REDUCTION; WHITE ADIPOSE TISSUE; ANIMAL; BLOOD; C57BL MOUSE; CLASSIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; METABOLISM; MOUSE MUTANT; PHYSIOLOGY;

MUS;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CHOLESTEROL; ENZYME-LINKED IMMUNOSORBENT ASSAY; INTERLEUKIN-18; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; TRANS-ACTIVATORS; TRIGLYCERIDES;

EID: 78149449130     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013539     Document Type: Article

References (52)

1. Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352: 1685-1695.
2. Puigserver P, Wu Z, Park CW, Graves R, Wright M, et al. (1998) A coldinducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92: 829-839.
3. Lin J, Handschin C, Spiegelman BM (2005) Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab 1: 361-370.
4. Vega RB, Huss JM, Kelly DP (2000) The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Mol Cell Biol 20: 1868-1876.
5. Wang YX, Lee CH, Tiep S, Yu RT, Ham J, et al. (2003) Peroxisomeproliferator- activated receptor delta activates fat metabolism to prevent obesity. Cell 113: 159-170.
6. Puigserver P, Spiegelman BM (2003) Peroxisome proliferator-activated receptorgamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr Rev 24: 78-90.
7. Oberkofler H, Schraml E, Krempler F, Patsch W (2003) Potentiation of liver X receptor transcriptional activity by peroxisome-proliferator-activated receptor gamma co-activator 1 alpha. Biochem J 371: 89-96.
8. Kressler D, Schreiber SN, Knutti D, Kralli A (2002) The PGC-1-related protein PERC is a selective coactivator of estrogen receptor alpha. J Biol Chem 277: 13918-13925.
9. Yoon JC, Puigserver P, Chen G, Donovan J, Wu Z, et al. (2001) Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 413: 131-138.
10. Puigserver P, Rhee J, Donovan J, Walkey CJ, Yoon JC, et al. (2003) Insulinregulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature 423: 550-555.
11. Lin J, Wu PH, Tarr PT, Lindenberg KS, St-Pierre J, et al. (2004) Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice. Cell 119: 121-135.
12. Kim HJ, Park KG, Yoo EK, Kim YH, Kim YN, et al. (2007) Effects of PGC- 1alpha on TNF-alpha-induced MCP-1 and VCAM-1 expression and NFkappaB activation in human aortic smooth muscle and endothelial cells. Antioxid Redox Signal 9: 301-307.
13. Won JC, Park JY, Kim YM, Koh EH, Seol S, et al. (2010) Peroxisome proliferator-activated receptor-gamma coactivator 1-alpha overexpression prevents endothelial apoptosis by increasing ATP/ADP translocase activity. Arterioscler Thromb Vasc Biol 30: 290-297.
14. Xie G, Guo D, Li Y, Liang S, Wu Y (2007) The impact of severity of hypertension on association of PGC-1alpha gene with blood pressure and risk of hypertension. BMC Cardiovasc Disord 7: 33.
15. Zhang Y, Xu W, Li X, Tang Y, Xie P, et al. (2008) Association between Ppargc1a Gene Polymorphisms and Coronary Artery Disease in a Chinese Population. Clin Exp Pharmacol Physiol.
16. Tontonoz P, Spiegelman BM (2008) Fat and Beyond: The Diverse Biology of PPARgamma. Annu Rev Biochem 77: 289-312.
17. Desvergne B, Wahli W (1999) Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 20: 649-688.
18. Ohman MK, Shen Y, Obimba CI, Wright AP, Warnock M, et al. (2008) Visceral adipose tissue inflammation accelerates atherosclerosis in apolipoprotein E-deficient mice. Circulation 117: 798-805.
19. See R, Abdullah SM, McGuire DK, Khera A, Patel MJ, et al. (2007) The association of differing measures of overweight and obesity with prevalent atherosclerosis: the Dallas Heart Study. J Am Coll Cardiol 50: 752-759.
20. Lakka HM, Lakka TA, Tuomilehto J, Salonen JT (2002) Abdominal obesity is associated with increased risk of acute coronary events in men. Eur Heart J 23: 706-713.
21. Elhage R, Jawien J, Rudling M, Ljunggren HG, Takeda K, et al. (2003) Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice. Cardiovasc Res 59: 234-240.
22. Tenger C, Sundborger A, Jawien J, Zhou X (2005) IL-18 accelerates atherosclerosis accompanied by elevation of IFN-gamma and CXCL16 expression independently of T cells. Arterioscler Thromb Vasc Biol 25: 791-796.
23. Li AC, Brown KK, Silvestre MJ, Willson TM, Palinski W, et al. (2000) Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice. J Clin Invest 106: 523-531.
24. Chawla A, Boisvert WA, Lee CH, Laffitte BA, Barak Y, et al. (2001) A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol Cell 7: 161-171.
25. Akiyama TE, Sakai S, Lambert G, Nicol CJ, Matsusue K, et al. (2002) Conditional disruption of the peroxisome proliferator-activated receptor gamma gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux. Mol Cell Biol 22: 2607-2619.
26. Mussig K, Staiger H, Machicao F, Thamer C, Machann J, et al. (2009) RARRES2, encoding the novel adipokine chemerin, is a genetic determinant of disproportionate regional body fat distribution: a comparative magnetic resonance imaging study. Metabolism 58: 519-524.
27. Wittamer V, Franssen JD, Vulcano M, Mirjolet JF, Le Poul E, et al. (2003) Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. J Exp Med 198: 977-985.
28. Lehrke M, Becker A, Greif M, Stark R, Laubender RP, et al. (2009) Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis. Eur J Endocrinol 161: 339-344.
29. Ploplis VA, Castellino FJ (2001) Attenuation of neointima formation following arterial injury in PAI-1 deficient mice. Ann N Y Acad Sci 936: 466-468.
30. Qian HS, Gu JM, Liu P, Kauser K, Halks-Miller M, et al. (2008) Overexpression of PAI-1 prevents the development of abdominal aortic aneurysm in mice. Gene Ther 15: 224-232.
31. Vaughan DE (2005) PAI-1 and atherothrombosis. J Thromb Haemost 3: 1879-1883.
32. Mallat Z, Corbaz A, Scoazec A, Graber P, Alouani S, et al. (2001) Interleukin- 18/interleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability. Circ Res 89: E41-45.
33. Whitman SC, Ravisankar P, Daugherty A (2002) Interleukin-18 enhances atherosclerosis in apolipoprotein E(2/2) mice through release of interferongamma. Circ Res 90: E34-38.
34. Hulthe J, McPheat W, Samnegard A, Tornvall P, Hamsten A, et al. (2006) Plasma interleukin (IL)-18 concentrations is elevated in patients with previous myocardial infarction and related to severity of coronary atherosclerosis independently of C-reactive protein and IL-6. Atherosclerosis 188: 450-454.
35. Suchanek H, Mysliwska J, Siebert J, Wieckiewicz J, Hak L, et al. (2005) High serum interleukin-18 concentrations in patients with coronary artery disease and type 2 diabetes mellitus. Eur Cytokine Netw 16: 177-185.
36. Matloubian M, David A, Engel S, Ryan JE, Cyster JG (2000) A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat Immunol 1: 298-304.
37. Shimaoka T, Kume N, Minami M, Hayashida K, Kataoka H, et al. (2000) Molecular cloning of a novel scavenger receptor for oxidized low density lipoprotein, SR-PSOX, on macrophages. J Biol Chem 275: 40663-40666.
38. Shimaoka T, Nakayama T, Fukumoto N, Kume N, Takahashi S, et al. (2004) Cell surface-anchored SR-PSOX/CXC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor 6-expressing cells. J Leukoc Biol 75: 267-274.
39. Shimaoka T, Nakayama T, Hieshima K, Kume N, Fukumoto N, et al. (2004) Chemokines generally exhibit scavenger receptor activity through their receptorbinding domain. J Biol Chem 279: 26807-26810.
40. Gough PJ, Garton KJ, Wille PT, Rychlewski M, Dempsey PJ, et al. (2004) A disintegrin and metalloproteinase 10-mediated cleavage and shedding regulates the cell surface expression of CXC chemokine ligand 16. J Immunol 172: 3678-3685.
41. Abel S, Hundhausen C, Mentlein R, Schulte A, Berkhout TA, et al. (2004) The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10. J Immunol 172: 6362-6372.
42. Mitsuoka H, Toyohara M, Kume N, Hayashida K, Jinnai T, et al. (2009) Circulating soluble SR-PSOX/CXCL16 as a biomarker for acute coronary syndrome -comparison with high-sensitivity C-reactive protein. J Atheroscler Thromb 16: 586-593.
43. Cook KS, Min HY, Johnson D, Chaplinsky RJ, Flier JS, et al. (1987) Adipsin: a circulating serine protease homolog secreted by adipose tissue and sciatic nerve. Science 237: 402-405.
44. Min HY, Spiegelman BM (1986) Adipsin, the adipocyte serine protease: gene structure and control of expression by tumor necrosis factor. Nucleic Acids Res 14: 8879-8892.
45. White RT, Damm D, Hancock N, Rosen BS, Lowell BB, et al. (1992) Human adipsin is identical to complement factor D and is expressed at high levels in adipose tissue. J Biol Chem 267: 9210-9213.
46. Flier JS, Cook KS, Usher P, Spiegelman BM (1987) Severely impaired adipsin expression in genetic and acquired obesity. Science 237: 405-408.
47. Recinos A 3rd, Carr BK, Bartos DB, Boldogh I, Carmical JR, et al. (2004) Liver gene expression associated with diet and lesion development in atherosclerosisprone mice: induction of components of alternative complement pathway. Physiol Genomics 19: 131-142.
48. Glass CK, Witztum JL (2001) Atherosclerosis. the road ahead. Cell 104: 503-516.
49. Plump AS, Smith JD, Hayek T, Aalto-Setala K, Walsh A, et al. (1992) Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71: 343-353.
50. Lutgens E, Gorelik L, Daemen MJ, de Muinck ED, Grewal IS, et al. (1999) Requirement for CD154 in the progression of atherosclerosis. Nat Med 5: 1313-1316.
51. Stein S, Lohmann C, Schäfer N, Hofmann J, Rohrer L, et al. (2010) SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis. Eur Heart J 31(18): 2301-2309.
52. Purcell-Huynh DA, Farese RV, Jr., Johnson DF, Flynn LM, Pierotti V, et al. (1995) Transgenic mice expressing high levels of human apolipoprotein B develop severe atherosclerotic lesions in response to a high-fat diet. J Clin Invest 95: 2246-2257.